Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 170 articles:
HTML format
Text format



Single Articles


    January 2017
  1. WEINMANN S, Naleway A, Swamy G, Krishnarajah G, et al
    Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.
    PLoS One. 2017;12:e0165276.
    PubMed     Text format     Abstract available


  2. ACERA A, Manresa JM, Rodriguez D, Rodriguez A, et al
    Increasing Cervical Cancer Screening Coverage: A Randomised, Community-Based Clinical Trial.
    PLoS One. 2017;12:e0170371.
    PubMed     Text format     Abstract available


  3. RAIFU AO, El-Zein M, Sangwa-Lugoma G, Ramanakumar A, et al
    Determinants of Cervical Cancer Screening Accuracy for Visual Inspection with Acetic Acid (VIA) and Lugol's Iodine (VILI) Performed by Nurse and Physician.
    PLoS One. 2017;12:e0170631.
    PubMed     Text format     Abstract available



  4. Correction: Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.
    PLoS One. 2017;12:e0172417.
    PubMed     Text format     Abstract available


  5. TEGUETE I, Dolo A, Sangare K, Sissoko A, et al
    Prevalence of HPV 16 and 18 and attitudes toward HPV vaccination trials in patients with cervical cancer in Mali.
    PLoS One. 2017;12:e0172661.
    PubMed     Text format     Abstract available


  6. YOO W, Kim S, Huh WK, Dilley S, et al
    Recent trends in racial and regional disparities in cervical cancer incidence and mortality in United States.
    PLoS One. 2017;12:e0172548.
    PubMed     Text format     Abstract available


  7. GAO Q, Lin S, Bai P, Du M, et al
    FZUImageReg: A toolbox for medical image registration and dose fusion in cervical cancer radiotherapy.
    PLoS One. 2017;12:e0174926.
    PubMed     Text format     Abstract available


  8. LABEIT AM, Peinemann F
    Determinants of a GP visit and cervical cancer screening examination in Great Britain.
    PLoS One. 2017;12:e0174363.
    PubMed     Text format     Abstract available


  9. NAWALE L, Dubey P, Chaudhari B, Sarkar D, et al
    Anti-proliferative effect of novel primary cetyl alcohol derived sophorolipids against human cervical cancer cells HeLa.
    PLoS One. 2017;12:e0174241.
    PubMed     Text format     Abstract available


  10. CHANG C, Hsieh MK, Chang WY, Chiang AJ, et al
    Determining the optimal number and location of cutoff points with application to data of cervical cancer.
    PLoS One. 2017;12:e0176231.
    PubMed     Text format     Abstract available


  11. WANG L, Shen H, Feng B, Zhu D, et al
    Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions.
    PLoS One. 2017;12:e0175520.
    PubMed     Text format     Abstract available


  12. CHEN M, Zhang Y, Zheng PS
    Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis.
    PLoS One. 2017;12:e0177171.
    PubMed     Text format     Abstract available


  13. MCKAY J, Tenet V, Franceschi S, Chabrier A, et al
    Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.
    PLoS One. 2017;12:e0177775.
    PubMed     Text format     Abstract available


  14. ASIEDU MN, Agudogo J, Krieger MS, Miros R, et al
    Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screening.
    PLoS One. 2017;12:e0177782.
    PubMed     Text format     Abstract available


  15. MCKAY J, Tenet V, Franceschi S, Chabrier A, et al
    Correction: Immuno-related polymorphisms and cervical cancer risk: The IARC multicentric case-control study.
    PLoS One. 2017;12:e0181285.
    PubMed     Text format     Abstract available


  16. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    PubMed     Text format     Abstract available


  17. CABRERA-BECERRIL A, Vargas-De-Leon C, Hernandez S, Miramontes P, et al
    Modeling the dynamics of chromosomal alteration progression in cervical cancer: A computational model.
    PLoS One. 2017;12:e0180882.
    PubMed     Text format     Abstract available


  18. AWEKE YH, Ayanto SY, Ersado TL
    Knowledge, attitude and practice for cervical cancer prevention and control among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: Community-based cross-sectional study.
    PLoS One. 2017;12:e0181415.
    PubMed     Text format     Abstract available


  19. SIGFRID L, Murphy G, Haldane V, Chuah FLH, et al
    Integrating cervical cancer with HIV healthcare services: A systematic review.
    PLoS One. 2017;12:e0181156.
    PubMed     Text format     Abstract available


  20. CHONGTHAWONSATID S
    Inequity of healthcare utilization on mammography examination and Pap smear screening in Thailand: Analysis of a population-based household survey.
    PLoS One. 2017;12:e0173656.
    PubMed     Text format     Abstract available


  21. JIANG Y, Chen C, Li L
    Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0170587.
    PubMed     Text format     Abstract available


  22. NOGUEIRA DIAS GENTA ML, Martins TR, Mendoza Lopez RV, Sadalla JC, et al
    Multiple HPV genotype infection impact on invasive cervical cancer presentation and survival.
    PLoS One. 2017;12:e0182854.
    PubMed     Text format     Abstract available


  23. KELLY HA, Ngou J, Chikandiwa A, Sawadogo B, et al
    Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
    PLoS One. 2017;12:e0174117.
    PubMed     Text format     Abstract available


  24. DEL MISTRO A, Frayle H, Rizzi M, Fantin G, et al
    Methylation analysis and HPV genotyping of self-collected cervical samples from women not responding to screening invitation and review of the literature.
    PLoS One. 2017;12:e0172226.
    PubMed     Text format     Abstract available


  25. DE GROOT AS, Tounkara K, Rochas M, Beseme S, et al
    Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali.
    PLoS One. 2017;12:e0171631.
    PubMed     Text format     Abstract available


  26. LEVENTAKOS K, Tsiodras S, Kelesidis T, Kefala M, et al
    gammaH2Ax Expression as a Potential Biomarker Differentiating between Low and High Grade Cervical Squamous Intraepithelial Lesions (SIL) and High Risk HPV Related SIL.
    PLoS One. 2017;12:e0170626.
    PubMed     Text format     Abstract available


  27. SIMMS KT, Hall M, Smith MA, Lew JB, et al
    Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
    PLoS One. 2017;12:e0163509.
    PubMed     Text format     Abstract available


  28. PALATNIK A, Ye S, Kendziorski C, Iden M, et al
    Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.
    PLoS One. 2017;12:e0181242.
    PubMed     Text format     Abstract available


  29. GARBA RM, Gadanya MA
    The role of intervention mapping in designing disease prevention interventions: A systematic review of the literature.
    PLoS One. 2017;12:e0174438.
    PubMed     Text format     Abstract available


  30. AZZOLLINI J, Pesenti C, Ferrari L, Fontana L, et al
    Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.
    PLoS One. 2017;12:e0171663.
    PubMed     Text format     Abstract available


  31. RHODES CM, Chang Y, Regan S, Triant VA, et al
    Non-Communicable Disease Preventive Screening by HIV Care Model.
    PLoS One. 2017;12:e0169246.
    PubMed     Text format     Abstract available


  32. LU Y, Wei JY, Yao DS, Pan ZM, et al
    Application of carbon nanoparticles in laparoscopic sentinel lymph node detection in patients with early-stage cervical cancer.
    PLoS One. 2017;12:e0183834.
    PubMed     Text format     Abstract available


  33. MUSA J, Achenbach CJ, O'Dwyer LC, Evans CT, et al
    Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0183924.
    PubMed     Text format     Abstract available


  34. GININDZA TG, Sartorius B, Dlamini X, Ostensson E, et al
    Cost analysis of Human Papillomavirus-related cervical diseases and genital warts in Swaziland.
    PLoS One. 2017;12:e0177762.
    PubMed     Text format     Abstract available


  35. JOO JH, Kim YS, Cho BC, Jeong CY, et al
    Variability in target delineation of cervical carcinoma: A Korean radiation oncology group study (KROG 15-06).
    PLoS One. 2017;12:e0173476.
    PubMed     Text format     Abstract available


  36. ELMI AA, Bansal D, Acharya A, Skariah S, et al
    Human Papillomavirus (HPV) Infection: Molecular Epidemiology, Genotyping, Seroprevalence and Associated Risk Factors among Arab Women in Qatar.
    PLoS One. 2017;12:e0169197.
    PubMed     Text format     Abstract available


  37. MEISAL R, Rounge TB, Christiansen IK, Eieland AK, et al
    HPV Genotyping of Modified General Primer-Amplicons Is More Analytically Sensitive and Specific by Sequencing than by Hybridization.
    PLoS One. 2017;12:e0169074.
    PubMed     Text format     Abstract available


  38. BERNAUDO S, Khazai S, Honarparvar E, Kopteva A, et al
    Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.
    PLoS One. 2017;12:e0179906.
    PubMed     Text format     Abstract available


  39. SLOTTA C, Schluter T, Ruiz-Perera LM, Kadhim HM, et al
    CRISPR/Cas9-mediated knockout of c-REL in HeLa cells results in profound defects of the cell cycle.
    PLoS One. 2017;12:e0182373.
    PubMed     Text format     Abstract available


  40. XI J, Chen J, Xu M, Yang H, et al
    Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China.
    PLoS One. 2017;12:e0182388.
    PubMed     Text format     Abstract available


  41. SABOL I, Milutin Gasperov N, Matovina M, Bozinovic K, et al
    Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.
    PLoS One. 2017;12:e0180480.
    PubMed     Text format     Abstract available


  42. YANEZ RJR, Lamprecht R, Granadillo M, Weber B, et al
    Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana.
    PLoS One. 2017;12:e0183177.
    PubMed     Text format     Abstract available


  43. ZHANG L, Xie F, Wang X, Peng D, et al
    Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China.
    PLoS One. 2017;12:e0180618.
    PubMed     Text format     Abstract available


  44. MCGRATH CJ, Garcia R, Trinh TT, Richardson BA, et al
    Role of p16 testing in cervical cancer screening among HIV-infected women.
    PLoS One. 2017;12:e0185597.
    PubMed     Text format     Abstract available


  45. BINKA C, Doku DT, Awusabo-Asare K
    Experiences of cervical cancer patients in rural Ghana: An exploratory study.
    PLoS One. 2017;12:e0185829.
    PubMed     Text format     Abstract available


  46. UEDA A, Takasawa A, Akimoto T, Takasawa K, et al
    Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
    PLoS One. 2017;12:e0184123.
    PubMed     Text format     Abstract available


  47. BOTWRIGHT S, Holroyd T, Nanda S, Bloem P, et al
    Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.
    PLoS One. 2017;12:e0182663.
    PubMed     Text format     Abstract available


  48. STANISAVLJEVIC D, Petrovic I, Vukovic V, Schwirtlich M, et al
    SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line.
    PLoS One. 2017;12:e0184686.
    PubMed     Text format     Abstract available


  49. KWAK YK, Lee SW, Kay CS, Park HH, et al
    Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.
    PLoS One. 2017;12:e0183339.
    PubMed     Text format     Abstract available


  50. HU X, Li S, Zhou L, Zhao M, et al
    Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies.
    PLoS One. 2017;12:e0183395.
    PubMed     Text format     Abstract available


  51. SCHMID BC, Carlson J, Rezniczek GA, Wyllie J, et al
    Examining word association networks: A cross-country comparison of women's perceptions of HPV testing and vaccination.
    PLoS One. 2017;12:e0185669.
    PubMed     Text format     Abstract available


    January 2016
  52. FIRNHABER C, Goeieman B, Faesen M, Levin S, et al
    Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa.
    PLoS One. 2016;11:e0144905.
    PubMed     Text format     Abstract available


  53. ROURA E, Travier N, Waterboer T, de Sanjose S, et al
    The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
    PLoS One. 2016;11:e0147029.
    PubMed     Text format     Abstract available


  54. NABER SK, Matthijsse SM, Rozemeijer K, Penning C, et al
    Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis.
    PLoS One. 2016;11:e0145548.
    PubMed     Text format     Abstract available


  55. BEKOLO CE, O'Bryan G, Tchago FE, Nangue C, et al
    Integrating Cervical Cancer Screening with HIV Care in Cameroon: Comparative Risk Analysis of Cervical Disease in HIV-Infected Women Receiving Antiretroviral Therapy to Women in the General Population.
    PLoS One. 2016;11:e0149152.
    PubMed     Text format     Abstract available


  56. ZHOU J, Li X, Huang K, Jia Y, et al
    Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery.
    PLoS One. 2016;11:e0149534.
    PubMed     Text format     Abstract available


  57. NDEJJO R, Mukama T, Musabyimana A, Musoke D, et al
    Uptake of Cervical Cancer Screening and Associated Factors among Women in Rural Uganda: A Cross Sectional Study.
    PLoS One. 2016;11:e0149696.
    PubMed     Text format     Abstract available


  58. VICI P, Buglioni S, Sergi D, Pizzuti L, et al
    DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.
    PLoS One. 2016;11:e0149872.
    PubMed     Text format     Abstract available


  59. BAYU H, Berhe Y, Mulat A, Alemu A, et al
    Cervical Cancer Screening Service Uptake and Associated Factors among Age Eligible Women in Mekelle Zone, Northern Ethiopia, 2015: A Community Based Study Using Health Belief Model.
    PLoS One. 2016;11:e0149908.
    PubMed     Text format     Abstract available


  60. KWON SB, Kim MJ, Yang JM, Lee HP, et al
    Cudrania tricuspidata Stem Extract Induces Apoptosis via the Extrinsic Pathway in SiHa Cervical Cancer Cells.
    PLoS One. 2016;11:e0150235.
    PubMed     Text format     Abstract available


  61. ROURA E, Travier N, Waterboer T, de Sanjose S, et al
    Correction: The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort.
    PLoS One. 2016;11:e0151427.
    PubMed     Text format     Abstract available


  62. ALFONZO E, Andersson Ellstrom A, Nemes S, Strander B, et al
    Effect of Fee on Cervical Cancer Screening Attendance-ScreenFee, a Swedish Population-Based Randomised Trial.
    PLoS One. 2016;11:e0150888.
    PubMed     Text format     Abstract available


  63. CAO Y, Zhou X, Huang X, Li Q, et al
    Correction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis.
    PLoS One. 2016;11:e0152830.
    PubMed     Text format     Abstract available


  64. TIAN Y, Ding W, Wang Y, Ji T, et al
    Correction: Ubiquitin B in Cervical Cancer: Critical for the Maintenance of Cancer Stem-Like Cell Characters.
    PLoS One. 2016;11:e0152813.
    PubMed     Text format     Abstract available


  65. ENERLY E, Bonde J, Schee K, Pedersen H, et al
    Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme.
    PLoS One. 2016;11:e0151978.
    PubMed     Text format     Abstract available


  66. AUDIRAC-CHALIFOUR A, Torres-Poveda K, Bahena-Roman M, Tellez-Sosa J, et al
    Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study.
    PLoS One. 2016;11:e0153274.
    PubMed     Text format     Abstract available


  67. PINKER K, Andrzejewski P, Baltzer P, Polanec SH, et al
    Multiparametric [18F]Fluorodeoxyglucose/ [18F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study.
    PLoS One. 2016;11:e0155333.
    PubMed     Text format     Abstract available


  68. NOWAKOWSKI A, Cybulski M, Buda I, Janosz I, et al
    Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland.
    PLoS One. 2016;11:e0155849.
    PubMed     Text format     Abstract available


  69. LEW JB, Simms K, Smith M, Lewis H, et al
    Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand.
    PLoS One. 2016;11:e0151619.
    PubMed     Text format     Abstract available


  70. IDEN M, Fye S, Li K, Chowdhury T, et al
    The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
    PLoS One. 2016;11:e0156274.
    PubMed     Text format     Abstract available


  71. FJELDBO CS, Aarnes EK, Malinen E, Kristensen GB, et al
    Identification and Validation of Reference Genes for RT-qPCR Studies of Hypoxia in Squamous Cervical Cancer Patients.
    PLoS One. 2016;11:e0156259.
    PubMed     Text format     Abstract available


  72. DEGREGORIO GA, Bradford LS, Manga S, Tih PM, et al
    Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon.
    PLoS One. 2016;11:e0157319.
    PubMed     Text format     Abstract available


  73. NAHVIJOU A, Daroudi R, Tahmasebi M, Amouzegar Hashemi F, et al
    Cost-Effectiveness of Different Cervical Screening Strategies in Islamic Republic of Iran: A Middle-Income Country with a Low Incidence Rate of Cervical Cancer.
    PLoS One. 2016;11:e0156705.
    PubMed     Text format     Abstract available


  74. ORANG'O EO, Wachira J, Asirwa FC, Busakhala N, et al
    Factors Associated with Uptake of Visual Inspection with Acetic Acid (VIA) for Cervical Cancer Screening in Western Kenya.
    PLoS One. 2016;11:e0157217.
    PubMed     Text format     Abstract available


  75. LIN CN, Liao YS, Chen WC, Wang YS, et al
    Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI.
    PLoS One. 2016;11:e0157820.
    PubMed     Text format     Abstract available


  76. SOUHO T, El Fatemi H, Karim S, El Rhazi K, et al
    Distribution of Carcinogenic Human Papillomavirus Genotypes and Association to Cervical Lesions among Women in Fez (Morocco).
    PLoS One. 2016;11:e0146246.
    PubMed     Text format     Abstract available


  77. TIAN WJ, Huang ML, Qin QF, Chen Q, et al
    Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0158787.
    PubMed     Text format     Abstract available


  78. MARTINEZ-NAVA GA, Fernandez-Nino JA, Madrid-Marina V, Torres-Poveda K, et al
    Cervical Cancer Genetic Susceptibility: A Systematic Review and Meta-Analyses of Recent Evidence.
    PLoS One. 2016;11:e0157344.
    PubMed     Text format     Abstract available


  79. GUO L, Lu X, Zheng L, Liu X, et al
    Association of Long Non-Coding RNA HOTAIR Polymorphisms with Cervical Cancer Risk in a Chinese Population.
    PLoS One. 2016;11:e0160039.
    PubMed     Text format     Abstract available


  80. HAMMAD AZIZ M, Fakhar-E-Alam M, Fatima M, Shaheen F, et al
    Photodynamic Effect of Ni Nanotubes on an HeLa Cell Line.
    PLoS One. 2016;11:e0150295.
    PubMed     Text format     Abstract available


  81. SONG T, Li N, Zarepisheh M, Li Y, et al
    An Automated Treatment Plan Quality Control Tool for Intensity-Modulated Radiation Therapy Using a Voxel-Weighting Factor-Based Re-Optimization Algorithm.
    PLoS One. 2016;11:e0149273.
    PubMed     Text format     Abstract available


  82. LEUNG DT, Lim PL, Cheung TH, Wong RR, et al
    Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients.
    PLoS One. 2016;11:e0160412.
    PubMed     Text format     Abstract available


  83. REBOLJ M, Bonde J, Preisler S, Ejegod D, et al
    Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.
    PLoS One. 2016;11:e0147326.
    PubMed     Text format     Abstract available


  84. PARK B, Kim SI, Seo SS, Kang S, et al
    Health Behaviors and Associated Sociodemographic Factors in Cervical Cancer Survivors Compared with Matched Non-Cancer Controls.
    PLoS One. 2016;11:e0160682.
    PubMed     Text format     Abstract available


  85. WHOP LJ, Baade P, Garvey G, Cunningham J, et al
    Cervical Abnormalities Are More Common among Indigenous than Other Australian Women: A Retrospective Record-Linkage Study, 2000-2011.
    PLoS One. 2016;11:e0150473.
    PubMed     Text format     Abstract available


  86. CASTILLO M, Astudillo A, Clavero O, Velasco J, et al
    Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.
    PLoS One. 2016;11:e0161403.
    PubMed     Text format     Abstract available


  87. KING AJ, Sonsma JA, Vriend HJ, van der Sande MA, et al
    Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.
    PLoS One. 2016;11:e0152782.
    PubMed     Text format     Abstract available


  88. CHANTHAVILAY P, Reinharz D, Mayxay M, Phongsavan K, et al
    Economic Evaluation of Screening Strategies Combined with HPV Vaccination of Preadolescent Girls for the Prevention of Cervical Cancer in Vientiane, Lao PDR.
    PLoS One. 2016;11:e0162915.
    PubMed     Text format     Abstract available


  89. HUANG Y, Li Y, Wang FF, Lv W, et al
    Over-Expressed miR-224 Promotes the Progression of Cervical Cancer via Targeting RASSF8.
    PLoS One. 2016;11:e0162378.
    PubMed     Text format     Abstract available


  90. REN J, Yuan W, Wang R, Wang Q, et al
    Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer.
    PLoS One. 2016;11:e0161932.
    PubMed     Text format     Abstract available


  91. LIU S, Song L, Yao H, Zhang L, et al
    MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1.
    PLoS One. 2016;11:e0163460.
    PubMed     Text format     Abstract available


  92. MITIKU I, Tefera F
    Knowledge about Cervical Cancer and Associated Factors among 15-49 Year Old Women in Dessie Town, Northeast Ethiopia.
    PLoS One. 2016;11:e0163136.
    PubMed     Text format     Abstract available


  93. CAMPOS NG, Sharma M, Clark A, Kim JJ, et al
    Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries.
    PLoS One. 2016;11:e0164000.
    PubMed     Text format     Abstract available


  94. ZHOU H, Wang Y, Lv Q, Zhang J, et al
    Overexpression of Ribosomal RNA in the Development of Human Cervical Cancer Is Associated with rDNA Promoter Hypomethylation.
    PLoS One. 2016;11:e0163340.
    PubMed     Text format     Abstract available


  95. ZHANG L, Qian H, Sha M, Luan Z, et al
    Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.
    PLoS One. 2016;11:e0164838.
    PubMed     Text format     Abstract available


  96. GAO D, Zhang Y, Zhu M, Liu S, et al
    miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.
    PLoS One. 2016;11:e0164701.
    PubMed     Text format     Abstract available


  97. STEFANOWICZ-HAJDUK J, Sparzak-Stefanowska B, Krauze-Baranowska M, Ochocka JR, et al
    Securinine from Phyllanthus glaucus Induces Cell Cycle Arrest and Apoptosis in Human Cervical Cancer HeLa Cells.
    PLoS One. 2016;11:e0165372.
    PubMed     Text format     Abstract available


  98. LI J, Wu MF, Lu HW, Zhang BZ, et al
    Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
    PLoS One. 2016;11:e0166612.
    PubMed     Text format     Abstract available


  99. RASHID S, Labani S, Das BC
    Knowledge, Awareness and Attitude on HPV, HPV Vaccine and Cervical Cancer among the College Students in India.
    PLoS One. 2016;11:e0166713.
    PubMed     Text format     Abstract available


  100. HUANG B, Cai J, Xu X, Guo S, et al
    High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence Risk.
    PLoS One. 2016;11:e0166311.
    PubMed     Text format     Abstract available


  101. ALFARO A, Juarez-Torres E, Medina-Martinez I, Mateos-Guerrero N, et al
    Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer.
    PLoS One. 2016;11:e0169315.
    PubMed     Text format     Abstract available


  102. ZHENG Q, Wang T, Jiang S, Han R, et al
    Production of Polyclonal Antibody to the HPV58 E7 Protein and Its Detection in Cervical Cancer.
    PLoS One. 2016;11:e0169138.
    PubMed     Text format     Abstract available


  103. SHARFO AW, Breedveld S, Voet PW, Heijkoop ST, et al
    Validation of Fully Automated VMAT Plan Generation for Library-Based Plan-of-the-Day Cervical Cancer Radiotherapy.
    PLoS One. 2016;11:e0169202.
    PubMed     Text format     Abstract available


  104. MARIANO VS, Lorenzi AT, Scapulatempo-Neto C, Stein MD, et al
    A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia.
    PLoS One. 2016;11:e0164892.
    PubMed     Text format     Abstract available


  105. WANG L, Wang P, Ren Y, Du J, et al
    Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China.
    PLoS One. 2016;11:e0160698.
    PubMed     Text format     Abstract available


  106. KHUNAMORNPONG S, Settakorn J, Sukpan K, Suprasert P, et al
    Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    PLoS One. 2016;11:e0158184.
    PubMed     Text format     Abstract available


  107. SMELOV V, Gheit T, Sundstrom K, Ploner A, et al
    Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study.
    PLoS One. 2016;11:e0156215.
    PubMed     Text format     Abstract available


  108. SETIAWAN D, Kotsopoulos N, Wilschut JC, Postma MJ, et al
    Assessment of the Broader Economic Consequences of HPV Prevention from a Government-Perspective: A Fiscal Analytic Approach.
    PLoS One. 2016;11:e0160707.
    PubMed     Text format     Abstract available


  109. MOLBAK K, Hansen ND, Valentiner-Branth P
    Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study.
    PLoS One. 2016;11:e0162520.
    PubMed     Text format     Abstract available


    January 2015
  110. GU J, Fu CY, Ng BK, Liu LB, et al
    Enhancement of early cervical cancer diagnosis with epithelial layer analysis of fluorescence lifetime images.
    PLoS One. 2015;10:e0125706.
    PubMed     Text format     Abstract available


  111. WAKATSUKI M, Kato S, Kiyohara H, Ohno T, et al
    Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508).
    PLoS One. 2015;10:e0127587.
    PubMed     Text format     Abstract available


  112. OSTENSSON E, Alder S, Elfstrom KM, Sundstrom K, et al
    Barriers to and facilitators of compliance with clinic-based cervical cancer screening: population-based cohort study of women aged 23-60 years.
    PLoS One. 2015;10:e0128270.
    PubMed     Text format     Abstract available


  113. TWINOMUJUNI C, Nuwaha F, Babirye JN
    Understanding the Low Level of Cervical Cancer Screening in Masaka Uganda Using the ASE Model: A Community-Based Survey.
    PLoS One. 2015;10:e0128498.
    PubMed     Text format     Abstract available



  114. Correction: BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer.
    PLoS One. 2015;10:e0129756.
    PubMed     Text format     Abstract available


  115. HIROSHIMA Y, Zhang Y, Zhao M, Zhang N, et al
    Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models.
    PLoS One. 2015;10:e0120358.
    PubMed     Text format     Abstract available


  116. PUNT S, Thijssen VL, Vrolijk J, de Kroon CD, et al
    Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.
    PLoS One. 2015;10:e0129119.
    PubMed     Text format     Abstract available


  117. SUH DH, Cho HY, Kim K, No JH, et al
    Matched-Case Comparisons in a Single Institution to Determine Critical Points for Inexperienced Surgeons' Successful Performances of Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy in Stage IA2-IIA Cervical Cancer.
    PLoS One. 2015;10:e0131170.
    PubMed     Text format     Abstract available


  118. HOOGENDAM JP, Zweemer RP, Verkooijen HM, de Jong PA, et al
    No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients.
    PLoS One. 2015;10:e0131899.
    PubMed     Text format     Abstract available


  119. YIN J, Wen J, Hang D, Han J, et al
    Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers-Hepatocellular Carcinoma and Cervical Cancer.
    PLoS One. 2015;10:e0132352.
    PubMed     Text format     Abstract available


  120. URSU RG, Onofriescu M, Luca A, Prisecariu LJ, et al
    The Need for Cervical Cancer Control in HIV-Positive and HIV-Negative Women from Romania by Primary Prevention and by Early Detection Using Clinically Validated HPV/DNA Tests.
    PLoS One. 2015;10:e0132271.
    PubMed     Text format     Abstract available


  121. JUNG PS, Kim DY, Lee SW, Park JY, et al
    Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting.
    PLoS One. 2015;10:e0132298.
    PubMed     Text format     Abstract available


  122. CATARINO R, Vassilakos P, Scaringella S, Undurraga-Malinverno M, et al
    Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar.
    PLoS One. 2015;10:e0134309.
    PubMed     Text format     Abstract available


  123. OSTENSSON E, Alder S, Elfstrom KM, Sundstrom K, et al
    Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years.
    PLoS One. 2015;10:e0135534.
    PubMed     Text format     Abstract available


  124. AGODI A, Barchitta M, Quattrocchi A, Maugeri A, et al
    DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis.
    PLoS One. 2015;10:e0135078.
    PubMed     Text format     Abstract available


  125. MASIKA MM, Ogembo JG, Chabeda SV, Wamai RG, et al
    Knowledge on HPV Vaccine and Cervical Cancer Facilitates Vaccine Acceptability among School Teachers in Kitui County, Kenya.
    PLoS One. 2015;10:e0135563.
    PubMed     Text format     Abstract available


  126. LIZARRAGA F, Ceballos-Cancino G, Espinosa M, Vazquez-Santillan K, et al
    Tissue Inhibitor of Metalloproteinase-4 Triggers Apoptosis in Cervical Cancer Cells.
    PLoS One. 2015;10:e0135929.
    PubMed     Text format     Abstract available


  127. JALAN S, Kanhaiya K, Rai A, Bandapalli OR, et al
    Network Topologies Decoding Cervical Cancer.
    PLoS One. 2015;10:e0135183.
    PubMed     Text format     Abstract available


  128. STEFANOWICZ-HAJDUK J, Bartoszewski R, Bartoszewska S, Kochan K, et al
    Pennogenyl Saponins from Paris quadrifolia L. Induce Extrinsic and Intrinsic Pathway of Apoptosis in Human Cervical Cancer HeLa Cells.
    PLoS One. 2015;10:e0135993.
    PubMed     Text format     Abstract available


  129. PETRILLO M, Zannoni GF, Martinelli E, Pedone Anchora L, et al
    Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer.
    PLoS One. 2015;10:e0136654.
    PubMed     Text format     Abstract available


  130. ADAMSON PC, Huchko MJ, Moss AM, Kinkel HF, et al
    Acceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South Africa.
    PLoS One. 2015;10:e0137299.
    PubMed     Text format     Abstract available


  131. DEMMENT MM, Peters K, Dykens JA, Dozier A, et al
    Developing the Evidence Base to Inform Best Practice: A Scoping Study of Breast and Cervical Cancer Reviews in Low- and Middle-Income Countries.
    PLoS One. 2015;10:e0134618.
    PubMed     Text format     Abstract available


  132. BARRON EV, Roman-Bassaure E, Sanchez-Sandoval AL, Espinosa AM, et al
    CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer.
    PLoS One. 2015;10:e0137397.
    PubMed     Text format     Abstract available


  133. CHONG GO, Jeong SY, Park SH, Lee YH, et al
    Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
    PLoS One. 2015;10:e0137743.
    PubMed     Text format     Abstract available


  134. COSTA RF, Longatto-Filho A, Pinheiro C, Zeferino LC, et al
    Historical Analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: A Time for Reflection.
    PLoS One. 2015;10:e0138945.
    PubMed     Text format     Abstract available


  135. ANDERSON J, Wysong M, Estep D, Besana G, et al
    Evaluation of Cervical Cancer Screening Programs in Cote d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.
    PLoS One. 2015;10:e0139242.
    PubMed     Text format     Abstract available


  136. MATTHIJSSE SM, van Rosmalen J, Hontelez JA, Bakker R, et al
    The Role of Acquired Immunity in the Spread of Human Papillomavirus (HPV): Explorations with a Microsimulation Model.
    PLoS One. 2015;10:e0116618.
    PubMed     Text format     Abstract available


  137. DARENG EO, Jedy-Agba E, Bamisaye P, Isa Modibbo F, et al
    Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening.
    PLoS One. 2015;10:e0141679.
    PubMed     Text format     Abstract available


  138. BRANDMAIER P, Purz S, Bremicker K, Hockel M, et al
    Simultaneous [18F]FDG-PET/MRI: Correlation of Apparent Diffusion Coefficient (ADC) and Standardized Uptake Value (SUV) in Primary and Recurrent Cervical Cancer.
    PLoS One. 2015;10:e0141684.
    PubMed     Text format     Abstract available


  139. ABBAS M, Kushwaha VS, Srivastava K, Banerjee M, et al
    Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
    PLoS One. 2015;10:e0142501.
    PubMed     Text format     Abstract available


  140. LINCE-DEROCHE N, Phiri J, Michelow P, Smith JS, et al
    Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
    PLoS One. 2015;10:e0141969.
    PubMed     Text format     Abstract available


  141. WAKATSUKI M, Kato S, Kiyohara H, Ohno T, et al
    Correction: Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508).
    PLoS One. 2015;10:e0143301.
    PubMed     Text format     Abstract available


  142. LEE JY, Kim YT, Kim S, Lee B, et al
    Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma.
    PLoS One. 2015;10:e0144887.
    PubMed     Text format     Abstract available


  143. CHOI J, Yoon HI, Lee J, Keum KC, et al
    Optimal Extent of Prophylactic Irradiation of Paraaortic Lymph Nodes in Patients with Uterine Cervical Cancer.
    PLoS One. 2015;10:e0145158.
    PubMed     Text format     Abstract available


  144. DI J, Rutherford S, Wu J, Song B, et al
    Knowledge of Cervical Cancer Screening among Women across Different Socio-Economic Regions of China.
    PLoS One. 2015;10:e0144819.
    PubMed     Text format     Abstract available


  145. WEI X, Zhang S, Cao D, Zhao M, et al
    Aberrant Hypermethylation of SALL3 with HPV Involvement Contributes to the Carcinogenesis of Cervical Cancer.
    PLoS One. 2015;10:e0145700.
    PubMed     Text format     Abstract available


  146. ZHANG W, Hou T, Niu C, Song L, et al
    B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer.
    PLoS One. 2015;10:e0144360.
    PubMed     Text format     Abstract available


  147. SCHNIPPEL K, Lince-Deroche N, van den Handel T, Molefi S, et al
    Cost evaluation of reproductive and primary health care mobile service delivery for women in two rural districts in South Africa.
    PLoS One. 2015;10:e0119236.
    PubMed     Text format     Abstract available


  148. JOHANSSON H, Bjelkenkrantz K, Darlin L, Dilllner J, et al
    Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities.
    PLoS One. 2015;10:e0124460.
    PubMed     Text format     Abstract available


  149. DAVIES KR, Cantor SB, Cox DD, Follen M, et al
    An alternative approach for estimating the accuracy of colposcopy in detecting cervical precancer.
    PLoS One. 2015;10:e0126573.
    PubMed     Text format     Abstract available


  150. SHARMA K, Kathait A, Jain A, Kujur K, et al
    Higher prevalence of human papillomavirus infection in adolescent and young adult girls belonging to different Indian tribes with varied socio-sexual lifestyle.
    PLoS One. 2015;10:e0125693.
    PubMed     Text format     Abstract available


  151. BUMRUNGTHAI S, Ekalaksananan T, Evans MF, Chopjitt P, et al
    Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues.
    PLoS One. 2015;10:e0127109.
    PubMed     Text format     Abstract available


  152. CHRISTIANSEN IK, Sandve GK, Schmitz M, Durst M, et al
    Transcriptionally Active Regions Are the Preferred Targets for Chromosomal HPV Integration in Cervical Carcinogenesis.
    PLoS One. 2015;10:e0119566.
    PubMed     Text format     Abstract available


  153. KINES RC, Zarnitsyn V, Johnson TR, Pang YY, et al
    Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles.
    PLoS One. 2015;10:e0120797.
    PubMed     Text format     Abstract available


  154. LI SW, Wu XL, Dong CL, Xie XY, et al
    The differential expression of OCT4 isoforms in cervical carcinoma.
    PLoS One. 2015;10:e0118033.
    PubMed     Text format     Abstract available


  155. PERSSON M, Elfstrom KM, Olsson SE, Dillner J, et al
    Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type.
    PLoS One. 2015;10:e0127444.
    PubMed     Text format     Abstract available


  156. WATSON-JONES D, Mugo N, Lees S, Mathai M, et al
    Access and Attitudes to HPV Vaccination amongst Hard-To-Reach Populations in Kenya.
    PLoS One. 2015;10:e0123701.
    PubMed     Text format     Abstract available


  157. HERWEIJER E, Feldman AL, Ploner A, Arnheim-Dahlstrom L, et al
    The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.
    PLoS One. 2015;10:e0134185.
    PubMed     Text format     Abstract available


  158. FONSECA AJ, Taeko D, Chaves TA, Amorim LD, et al
    HPV Infection and Cervical Screening in Socially Isolated Indigenous Women Inhabitants of the Amazonian Rainforest.
    PLoS One. 2015;10:e0133635.
    PubMed     Text format     Abstract available


  159. DE OLIVEIRA LM, Morale MG, Chaves AA, Cavalher AM, et al
    Design, Immune Responses and Anti-Tumor Potential of an HPV16 E6E7 Multi-Epitope Vaccine.
    PLoS One. 2015;10:e0138686.
    PubMed     Text format     Abstract available


  160. JINDRA C, Huber B, Shafti-Keramat S, Wolschek M, et al
    Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.
    PLoS One. 2015;10:e0138722.
    PubMed     Text format     Abstract available


  161. OSTENSSON E, Froberg M, Leval A, Hellstrom AC, et al
    Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    PLoS One. 2015;10:e0139062.
    PubMed     Text format     Abstract available


  162. DING X, Jiang W, Zhou P, Liu L, et al
    Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7).
    PLoS One. 2015;10:e0145023.
    PubMed     Text format     Abstract available


    January 2014
  163. MUHWEZI WW, Banura C, Turiho AK, Mirembe F, et al
    Parents' Knowledge, Risk Perception and Willingness to Allow Young Males to Receive Human Papillomavirus (HPV) Vaccines in Uganda.
    PLoS One. 2014;9:e106686.
    PubMed     Text format     Abstract available


  164. GUILLAUD M, Buys TP, Carraro A, Korbelik J, et al
    Evaluation of HPV Infection and Smoking Status Impacts on Cell Proliferation in Epithelial Layers of Cervical Neoplasia.
    PLoS One. 2014;9:e107088.
    PubMed     Text format     Abstract available


  165. KIATPONGSAN S, Kim JJ
    Costs and Cost-Effectiveness of 9-Valent Human Papillomavirus (HPV) Vaccination in Two East African Countries.
    PLoS One. 2014;9:e106836.
    PubMed     Text format     Abstract available


  166. VERMANDERE H, Naanyu V, Mabeya H, Vanden Broeck D, et al
    Determinants of Acceptance and Subsequent Uptake of the HPV Vaccine in a Cohort in Eldoret, Kenya.
    PLoS One. 2014;9:e109353.
    PubMed     Text format     Abstract available


  167. XU LD, Muller S, Thoppe SR, Hellborg F, et al
    Expression of the p53 Target Wig-1 Is Associated with HPV Status and Patient Survival in Cervical Carcinoma.
    PLoS One. 2014;9:e111125.
    PubMed     Text format     Abstract available


  168. HOFMAN R, de Bekker-Grob EW, Richardus JH, de Koning HJ, et al
    Have Preferences of Girls Changed Almost 3 Years after the Much Debated Start of the HPV Vaccination Program in the Netherlands? A Discrete Choice Experiment.
    PLoS One. 2014;9:e104772.
    PubMed     Text format     Abstract available


  169. BOERS A, Slagter-Menkema L, van Hemel BM, Belinson JL, et al
    Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off.
    PLoS One. 2014;9:e101930.
    PubMed     Text format     Abstract available


  170. WANG T, Zeng X, Li W, Zhu H, et al
    Detection and Analysis of Human Papillomavirus (HPV) DNA in Breast Cancer Patients by an Effective Method of HPV Capture.
    PLoS One. 2014;9:e90343.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: